← Back to directory

Mahmut Gümüş

Researcher Next ID · RN-010020

Researcher · Medicine

Istanbul Eye Hospital

, Turkey

Not currently recruitingFunding unknown
Works count
332
Citation count
18,814
H-index
38
i10-index
123

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Gastric Cancer Management and Outcomes
Colorectal Cancer Treatments and Studies
Breast Cancer Treatment Studies

Publications

  • Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

    New England Journal of Medicine · 2024 · 10.1056/nejmoa2312117

  • Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet · 2023 · 10.1016/s0140-6736(23)00727-4

  • Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

    New England Journal of Medicine · 2021 · 10.1056/nejmoa2112435

  • Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

    The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7

  • Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1810865

Current projects

    No projects listed.